cabazitaxel
sanofi
['cabazitaxel']
#esmo22 pca:
- 8-mo psa pfs, prognostic factor in hspc
- cabazitaxel 16/m2/2w in the elderly the rest only academic interest: negative studies, indirect comparisons, possible prognostic bmk, immature os, psa pfs, qol, and an incomplete meta-analysis. and very often at home: 
De momento, aquí y ahora. 
Después, ya veremos.